Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Anaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06245746
What this trial is testing

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaNeutropeniaAnemia+3 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 9
Not applicableApproved For MarketingNCT04504513
What this trial is testing

Expanded Access to Trilaciclib for Patients Receiving Chemotherapy for Small Cell Lung Cancer

Who this might be right for
Myelosuppression AdultChemotherapeutic ToxicitySmall Cell Lung Cancer
G1 Therapeutics, Inc.
Large-scale testing (Phase 3)Study completedNCT00144482
What this trial is testing

Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Who this might be right for
Chemotherapy Induced Anemia
Chugai Pharmaceutical 122
Not applicableStudy completedNCT01933035
What this trial is testing

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

Who this might be right for
Immune ThrombocytopeniaChemotherapy Induced ThrombocytopeniaMyelodysplasia+1 more
Beth Israel Medical Center 50
Large-scale testing (Phase 3)UnknownNCT00482716
What this trial is testing

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+2 more
St. Bartholomew's Hospital 80
Large-scale testing (Phase 3)Study completedNCT00628043
What this trial is testing

Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients

Who this might be right for
Anemia
Chugai Pharmaceutical 160
Testing effectiveness (Phase 2)Study completedNCT05963334
What this trial is testing

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Advanced Epithelial Ovarian Cancer
Cairo University 49
Large-scale testing (Phase 3)UnknownNCT00002926
What this trial is testing

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 80
Testing effectiveness (Phase 2)Ended earlyNCT00306267
What this trial is testing

PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy

Who this might be right for
AnemiaCancerEpoetin Alfa
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 61
Testing effectiveness (Phase 2)Study completedNCT00111462
What this trial is testing

Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy

Who this might be right for
AnemiaNon-Myeloid MalignanciesCancer
Amgen
Testing effectiveness (Phase 2)Ended earlyNCT00931606
What this trial is testing

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

Who this might be right for
Chemotherapy Induced Anemia
Merck Sharp & Dohme LLC 30
Not applicableStudy completedNCT01626547
What this trial is testing

Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnaemiaSolid TumoursMalignant Lymphomas+1 more
Hospira, now a wholly owned subsidiary of Pfizer 291
Large-scale testing (Phase 3)Ended earlyNCT00858364
What this trial is testing

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Who this might be right for
Non-Small Cell Lung CancerAnemiaCancer+1 more
Amgen 2,549
Testing effectiveness (Phase 2)Study completedNCT00272662
What this trial is testing

Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy

Who this might be right for
Chemotherapy Induced AnemiaCancer
Affymax 60
Large-scale testing (Phase 3)Study completedNCT00148421
What this trial is testing

Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.

Who this might be right for
Anemia
Amgen
Early research (Phase 1)Study completedNCT04667533
What this trial is testing

Desidustat in the Treatment of Chemotherapy Induced Anemia

Who this might be right for
Anemia of Chronic Kidney DiseaseChemotherapy Effect
Zydus Lifesciences Limited 24
Testing effectiveness (Phase 2)Looking for participantsNCT07663864
What this trial is testing

Luspatercept for CIA in AML

Who this might be right for
Chemotherapy-inducing Anemia
Guangdong Second Provincial General Hospital 40
Testing effectiveness (Phase 2)Study completedNCT04076943
What this trial is testing

Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia

Who this might be right for
Chemotherapy Induced Anemia
Kyntra Bio 92
Testing effectiveness (Phase 2)Study completedNCT00338416
What this trial is testing

An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks

Who this might be right for
CancerAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 115
Not applicableLooking for participantsNCT06809101
What this trial is testing

Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.

Who this might be right for
CancerCancer-related Problem/ConditionChemotherapy+3 more
Pomeranian Medical University Szczecin 265
Next Page